Medroxyprogesterone Acetate Injection, all strengths and all presentations including a) Medroxyprogesterone 150-30 mL, b) Medroxyprogesterone Acetate 150 mg/mL in 1 mL, 10 mL, 30 mL vials, c) Medroxyprogesterone Acetate 150 mg/mL PF syringe, d) Medroxyprogesterone Acetate 150 mg/mL syringe, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
Published May 22, 2013 · Recall initiated: April 10, 2013
Summary
FDA records drug Class II recall D-386-2013, published May 22, 2013 and initiated April 10, 2013. Recalling firm: FVS Holdings, Inc. dba. Green Valley Drugs; Status: Terminated; Reported quantity: 1299 vials and syringes; Lot: Lot #: a) Medroxyprogesterone 150-30 mL: 20130301-H, Exp 6/1/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Distributor
- Nationwide
- Lot
- Lot #: a) Medroxyprogesterone 150-30 mL: 20130301-H, Exp 6/1/2013.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMIC Vitamin Injection, all strengths and all presentations including a) MIC 25-50-25-30 mL, b)May 22, 2013
- FDAMethylprednisolone and Dexamethasone Injection, all strengths and all presentations including a) Methylpred/May 22, 2013
- FDABacteriostatic Water for Injection, all presentations including 30 mL, Rx only, Green Valley Drugs, 1850May 22, 2013
- FDAMethylprednisolone and Bupivacaine Injection, all strengths and all presentations includingMay 22, 2013
- FDAManganese Sulfate Injection, all strengths and all presentations including a) Manganese-0.1 30 mL, b)May 22, 2013
- FDAMethylcobalamin Injection, all strengths and all presentations including a) Methylcobalamin 1000 mcg/mL in 10May 22, 2013
Questions about this recall
Was Medroxyprogesterone Acetate Injection, all strengths and all presentations including a) Medroxyprogesterone 150-30 mL, b) Medroxyprogesterone Acetate 150 mg/mL in 1 mL, 10 mL, 30 mL vials, c) Medroxyprogesterone Acetate 150 mg/mL PF syringe, d) Medroxyprogesterone Acetate 150 mg/mL syringe, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014. recalled?
Yes. FDA published recall D-386-2013 on May 22, 2013. Reported hazard: Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release